Entero Therapeutics Inc [NASDAQ: ENTO] price surged by 3.53 percent to reach at $0.02.
A sum of 20982539 shares traded at recent session while its average daily volume was at 1.30M shares. Entero Therapeutics Inc shares reached a high of $0.57 and dropped to a low of $0.441 until finishing in the latest session at $0.55.
The one-year ENTO stock forecast points to a potential upside of 98.47. The average equity rating for ENTO stock is currently 1.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Entero Therapeutics Inc [ENTO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ENTO shares is $36.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ENTO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
ENTO Stock Performance Analysis:
Entero Therapeutics Inc [ENTO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 40.54. With this latest performance, ENTO shares gained by 5.54% in over the last four-week period, additionally sinking by -11.48% over the last 6 months – not to mention a drop of -11.77% in the past year of trading.
Insight into Entero Therapeutics Inc Fundamentals:
Return on Equity for this stock declined to -25.32%, with Return on Assets sitting at -25.32%.
Entero Therapeutics Inc [ENTO] Institutonal Ownership Details
There are presently around $3.07%, or 3.31% of ENTO stock, in the hands of institutional investors.
